Peter G. Traber
2021 - SELECTA BIOSCIENCES
In 2021, Peter G. Traber earned a total compensation of $1.6M as Chief Medical Officer at SELECTA BIOSCIENCES, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $181,000 |
|---|---|
| Option Awards | $704,679 |
| Salary | $440,000 |
| Stock Awards | $253,445 |
| Other | $21,561 |
| Total | $1,600,685 |
Traber received $704.7K in option awards, accounting for 44% of the total pay in 2021.
Traber also received $181K in non-equity incentive plan, $440K in salary, $253.4K in stock awards and $21.6K in other compensation.
Rankings
In 2021, Peter G. Traber's compensation ranked 6,974th out of 12,412 executives tracked by ExecPay. In other words, Traber earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,974 out of 12,412 | 44th |
Division Manufacturing | 3,051 out of 5,498 | 45th |
Major group Chemicals And Allied Products | 1,352 out of 2,374 | 43rd |
Industry group Drugs | 1,206 out of 2,095 | 42nd |
Industry Pharmaceutical Preparations | 877 out of 1,542 | 43rd |
Source: SEC filing on May 3, 2022.
Traber's colleagues
We found six more compensation records of executives who worked with Peter G. Traber at SELECTA BIOSCIENCES in 2021.
2021
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
2021
Kevin Tan
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Takashi Kishimoto
SELECTA BIOSCIENCES
Chief Scientific Officer
2021
Lloyd Johnston
SELECTA BIOSCIENCES
Chief Operations Officer
2021
Bradford Dahms
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Ann Donohue
SELECTA BIOSCIENCES